Erlocip (Erlotinib)

Erlocip

Erlotinib

* Our best price : $ 262.40

Erlocip (Erlotinib) is an anti-cancer medication which works by blocking the epidermal growth factor receptor (EGFR). This helps to inhibit the growth of cancer cells. Indications include first line treatment of metastatic NSCLC (non-small cell lung cancer) and pancreatic cancer.

Brand Name : Erlocip
Active Ingredients : Erlotinib
Manufacturer : Cipla
Country of Origin : India
Intended Patient : Unisex
Erlocip-100 (Erlotinib) - 100mg (30 Tablets) Erlocip-100 (Erlotinib) - 100mg (30 Tablets)
Out of stock
* Quantity
1 Bottle(s) +
Price / Each
$262.40
Erlocip-150 (Erlotinib) - 150mg (30 Tablets) Erlocip-150 (Erlotinib) - 150mg (30 Tablets)
Out of stock
* Quantity
1 Bottle(s) +
Price / Each
$342.20

Description


Uses

Erlocip (Erlotinib) is an anti-cancer medication which works by blocking the epidermal growth factor receptor (EGFR). This helps to inhibit the growth of cancer cells. Indications include first line treatment of metastatic NSCLC (non-small cell lung cancer) and pancreatic cancer. Patients being treated for pancreatic cancer will also be treated with another cancer medicine (gemcitabine). The main ingredient in this drug is classified as a kinase inhibitor.

Its mechanism of action is inhibiting the kinase activity of the epidermal growth factor receptor (EGFR). The EGFRs are present on the cell surface and they help the epidermal growth factor (a type of protein which is known to stimulate the growth of cells) attach itself to the cells, resulting in the activation of an enzyme known as tyrosine kinase. This enzyme helps trigger growth in the cancer cells.

However, this medicine reversibly inhibits EGFR action, which disrupts the entire chemical process that causes the growth of the cancer cells, thereby preventing the multiplication of the cancer cells. Medical tests may be required by your physician to determine whether or not the cancer is likely to be responsive to treatment with this medicine.

Dosage and Administration

Erlocip (Erlotinib) is provided as tablet form. There is a 100mg strength version available, as well as 150mg strength tablets. Your physician will determine which one is most suitable. The medicine is generally administered 1 hour prior to consumption of food or else 2 hours after eating. In some cases, patients treating small cell lung cancer may be told by their physician to take 150mg once per day. Adult patients treating pancreatic cancer are sometimes directed by the physician providing medical treatment to take 100mg per day.

Side effects

Erlocip (Erlotinib) can cause side effects. You must tell the physician in charge of treatment if this occurs. Some examples are listed here:

  • Acne
  • Hair loss
  • Tiredness
  • Reduced appetite
  • Loss of body weight

There is also the possibility that serious adverse events will occur. You will need to see your physician or go to the hospital immediately if you suffer from peeling of the skin, fever, pain affecting the eyes, numb limbs, bruising or any other severe side effects not referenced here.

Precautions

Should you forget to take a dose of Erlocip (Erlotinib) at any time, call your physician immediately for advice on what to do.

Your physician may advise against consuming grapefruit or drinking grapefruit juice, as doing so could trigger an increase in the blood levels of the medicine.

This product is added. Thank you.

 Please choose your option:

0
My Cart : 0 Items $0.00

Shopping Cart

 

Your cart is empty